Rudi Bao

1.8k total citations
19 papers, 1.5k citations indexed

About

Rudi Bao is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Rudi Bao has authored 19 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Rudi Bao's work include Histone Deacetylase Inhibitors Research (6 papers), Protein Degradation and Inhibitors (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Rudi Bao is often cited by papers focused on Histone Deacetylase Inhibitors Research (6 papers), Protein Degradation and Inhibitors (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Rudi Bao collaborates with scholars based in United States, Japan and Canada. Rudi Bao's co-authors include Thomas C. Hamilton, Muthu Selvakumaran, Changgeng Qian, Cheng-Jung Lai, Ling Yin, Hai-Xiao Zhai, Hui Qu, Anthony T. Yeung, Xiong Cai and Jeffrey Forrester and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Rudi Bao

18 papers receiving 1.4k citations

Peers

Rudi Bao
Karen S. Flatten United States
Yukimasa Shiotsu Japan
Shar-yin N. Huang United States
Alfred M. Rogan Austria
Muthu Selvakumaran United States
Silvia Prislei Italy
Cherrie K. Donawho United States
Danhui Weng China
George E. Durán United States
Martina Bazzaro United States
Karen S. Flatten United States
Rudi Bao
Citations per year, relative to Rudi Bao Rudi Bao (= 1×) peers Karen S. Flatten

Countries citing papers authored by Rudi Bao

Since Specialization
Citations

This map shows the geographic impact of Rudi Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rudi Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rudi Bao more than expected).

Fields of papers citing papers by Rudi Bao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rudi Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rudi Bao. The network helps show where Rudi Bao may publish in the future.

Co-authorship network of co-authors of Rudi Bao

This figure shows the co-authorship network connecting the top 25 collaborators of Rudi Bao. A scholar is included among the top collaborators of Rudi Bao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rudi Bao. Rudi Bao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Liu, Ningbo, Yang Chen, Lujun Zhao, et al.. (2016). The radiation sensitization effect of newly discovered EGFR specific inhibitor HS-10182 in human lung cells.. Journal of Clinical Oncology. 34(15_suppl). e20635–e20635.
3.
Qian, Changgeng, Cheng-Jung Lai, Rudi Bao, et al.. (2012). Cancer Network Disruption by a Single Molecule Inhibitor Targeting Both Histone Deacetylase Activity and Phosphatidylinositol 3-Kinase Signaling. Clinical Cancer Research. 18(15). 4104–4113. 188 indexed citations
4.
Bao, Rudi, et al.. (2011). Novel compounds in the treatment of lung cancer: current and developing therapeutic agents. Journal of Experimental Pharmacology. 3. 21–21. 6 indexed citations
5.
Bao, Rudi, Da-Gong Wang, Hui Qu, et al.. (2011). Abstract 2615: Antitumor activity of a dual PI3K and HDAC inhibitor in hematologic cancer models. Cancer Research. 71(8_Supplement). 2615–2615. 1 indexed citations
6.
7.
Cai, Xiong, Hai-Xiao Zhai, Jing Wang, et al.. (2010). Discovery of 7-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide (CUDC-101) as a Potent Multi-Acting HDAC, EGFR, and HER2 Inhibitor for the Treatment of Cancer. Journal of Medicinal Chemistry. 53(5). 2000–2009. 218 indexed citations
8.
Bao, Rudi, Cheng-Jung Lai, Hui Qu, et al.. (2009). CUDC-305, a Novel Synthetic HSP90 Inhibitor with Unique Pharmacologic Properties for Cancer Therapy. Clinical Cancer Research. 15(12). 4046–4057. 80 indexed citations
9.
Bao, Rudi, Cheng-Jung Lai, Da-Gong Wang, et al.. (2009). Targeting heat shock protein 90 with CUDC-305 overcomes erlotinib resistance in non–small cell lung cancer. Molecular Cancer Therapeutics. 8(12). 3296–3306. 47 indexed citations
10.
Liu, Shumei, Yue Liu, Le Zhang, et al.. (2008). CU-0201, a potent, small molecule, multi-targeted inhibitor of HDAC, Abl and Src, effectively inhibits proliferation of both hematological and solid-tumor derived cancer cell lines. 68. 5717–5717. 2 indexed citations
11.
Stewart, Sherri L., Troy D. Querec, Rudi Bao, et al.. (2004). Characterization of a Carcinogenesis Rat Model of Ovarian Preneoplasia and Neoplasia. Cancer Research. 64(22). 8177–8183. 52 indexed citations
12.
Lassota, Peter, Erik J. Sorensen, Rudi Bao, et al.. (2004). NVP-LBH589, a novel histone deacetylase inhibitor, activates caspase-3 and induces apoptosis of human tumor cells in vivo. Cancer Research. 64. 927–927. 2 indexed citations
13.
Garson, Kenneth, Elizabeth A. Macdonald, Manon Dubé, et al.. (2003). Generation of Tumors in Transgenic Mice Expressing the SV40 T Antigen Under the Control of Ovarian-Specific Promoter 1. Journal of the Society for Gynecologic Investigation. 10(4). 244–250. 21 indexed citations
14.
Connolly, Denise C., Rudi Bao, Alexander Yu. Nikitin, et al.. (2003). Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer.. PubMed. 63(6). 1389–97. 244 indexed citations
15.
Selvakumaran, Muthu, et al.. (2003). Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines.. PubMed. 63(6). 1311–6. 266 indexed citations
16.
Capo‐chichi, Callinice D., Isabelle Roland, Lisa Vanderveer, et al.. (2003). Anomalous expression of epithelial differentiation-determining GATA factors in ovarian tumorigenesis.. PubMed. 63(16). 4967–77. 70 indexed citations
17.
Bao, Rudi, Muthu Selvakumaran, & Thomas C. Hamilton. (2002). Targeted Gene Therapy of Ovarian Cancer Using an Ovarian-Specific Promoter. Gynecologic Oncology. 84(2). 228–234. 17 indexed citations
18.
Bao, Rudi, Muthu Selvakumaran, & Thomas C. Hamilton. (2000). Use of a Surrogate Marker (Human Secreted Alkaline Phosphatase) to Monitor in Vivo Tumor Growth and Anticancer Drug Efficacy in Ovarian Cancer Xenografts. Gynecologic Oncology. 78(3). 373–379. 29 indexed citations
19.
Abdollahi, Abbas, Rudi Bao, & Thomas C. Hamilton. (1999). LOT1 is a growth suppressor gene down-regulated by the epidermal growth factor receptor ligands and encodes a nuclear zinc-finger protein. Oncogene. 18(47). 6477–6487. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karen S. Flatten Breakdown of academic impact, for papers by Yukimasa Shiotsu Breakdown of academic impact, for papers by Shar-yin N. Huang Breakdown of academic impact, for papers by Alfred M. Rogan Breakdown of academic impact, for papers by Muthu Selvakumaran Breakdown of academic impact, for papers by Silvia Prislei Breakdown of academic impact, for papers by Cherrie K. Donawho Breakdown of academic impact, for papers by Danhui Weng Breakdown of academic impact, for papers by George E. Durán Breakdown of academic impact, for papers by Martina Bazzaro
Rankless by CCL
2026